Sign In
Buy HRTX
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Baxter International (BAX – Research
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by Zacks Investment Research
06:48am, Thursday, 30'th Apr 2020
Heron Therapeutics (NASDAQ:HRTX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Thursday, Zacks.com reports. According to Zacks, “Her
How Much Did Heron Therapeutics, Inc.’s (NASDAQ:HRTX) CEO Pocket Last Year?
11:52am, Tuesday, 28'th Apr 2020
In 2013, Barry Quart was appointed CEO of Heron Therapeutics, Inc. (NASDAQ:HRTX). First, this article will compare CEO...
Analysts Anticipate Heron Therapeutics Inc (NASDAQ:HRTX) Will Announce Quarterly Sales of $20.89 Million
09:54am, Sunday, 26'th Apr 2020
Brokerages predict that Heron Therapeutics Inc (NASDAQ:HRTX) will post sales of $20.89 million for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Heron Therape
Brokerages Anticipate Heron Therapeutics Inc (NASDAQ:HRTX) to Post -$0.62 Earnings Per Share
06:14am, Friday, 24'th Apr 2020
Analysts expect Heron Therapeutics Inc (NASDAQ:HRTX) to report earnings of ($0.62) per share for the current quarter, according to Zacks. Four analysts have issued estimates for Heron Therapeutics’
Heron Therapeutics (NASDAQ:HRTX) Lowered to "Sell" at Zacks Investment Research
06:30am, Wednesday, 22'nd Apr 2020
Heron Therapeutics (NASDAQ:HRTX) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “
3 “Strong Buy” Biotech Stocks with FDA Approvals on the Horizon
11:02am, Sunday, 19'th Apr 2020
COVID-19 has turned the world upside down, with the deadly virus inducing an unprecedented level of panic. Crushing economies across the globe, stocks seem to be taking hits left and right as the mark
3 "Strong Buy" Biotech Stocks with FDA Approvals on the Horizon
11:01am, Sunday, 19'th Apr 2020
COVID-19 has turned the world upside down, but the market’s most recent surge has Wall Street observers wondering if the situation is on the
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX)
10:38am, Wednesday, 15'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Heron Therapeutics (HRTX) today and set a price target of $44.00. The company's shares closed
Needham Keeps Their Buy Rating on Heron Therapeutics (HRTX)
10:38am, Wednesday, 15'th Apr 2020
Needham analyst
Serge Belanger
maintained a
Buy
rating on Heron Therapeutics (
HRTX
–
Research Report
) today and set a price target of
$44.00
. The company’s shares closed last Tuesday at $14.85.
Heron Therapeutics Inc (NASDAQ:HRTX) Shares Acquired by Nuveen Asset Management LLC
10:48am, Tuesday, 14'th Apr 2020
Nuveen Asset Management LLC raised its holdings in Heron Therapeutics Inc (NASDAQ:HRTX) by 83.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commiss
Alliancebernstein L.P. Acquires 3,100 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
08:42am, Tuesday, 14'th Apr 2020
Alliancebernstein L.P. lifted its holdings in Heron Therapeutics Inc (NASDAQ:HRTX) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The
Geode Capital Management LLC Raises Holdings in Heron Therapeutics Inc (NASDAQ:HRTX)
09:18am, Monday, 13'th Apr 2020
Geode Capital Management LLC grew its stake in shares of Heron Therapeutics Inc (NASDAQ:HRTX) by 22.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,132,260 shares of the biote
Bank of New York Mellon Corp Purchases 28,982 Shares of Heron Therapeutics Inc (NASDAQ:HRTX)
08:36am, Monday, 13'th Apr 2020
Bank of New York Mellon Corp lifted its position in Heron Therapeutics Inc (NASDAQ:HRTX) by 8.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Those Who Purchased Heron Therapeutics (NASDAQ:HRTX) Shares A Year Ago Have A 42% Loss To Show For It
11:21am, Friday, 10'th Apr 2020
This week we saw the Heron Therapeutics, Inc. (NASDAQ:HRTX) share price climb by 24%. But that is minimal compensation...
